Company Filing History:
Years Active: 1991
Title: Albrecht V Hodenberg: Innovator in Antiarrhythmic Agents
Introduction
Albrecht V Hodenberg is a notable inventor based in Kenzingen, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of antiarrhythmic agents. His work has implications for the treatment of heart conditions, showcasing the importance of innovation in medical science.
Latest Patents
Hodenberg holds a patent for "Metabolites of pirmenol." This invention relates to the + or - pirmenol stereoisomers and selected metabolites of pirmenol or (+,-)-cis-.alpha.-[3-(2,6-dimethyl-1-piperidinyl))propyl]-.alpha.-phenyl-2-pyridinemethanol. These compounds are recognized for their activity as antiarrhythmic agents. The patent also covers pharmaceutical compositions that include these metabolites, emphasizing their potential therapeutic applications.
Career Highlights
Throughout his career, Hodenberg has been associated with Warner-Lambert Company, where he has contributed to various research initiatives. His work has focused on the pharmacological use of metabolites, particularly in the context of heart health. His innovative approach has led to advancements in the development of effective treatments for arrhythmias.
Collaborations
Hodenberg has collaborated with notable colleagues, including Timothy R Hurley and Dino A Sherwood. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmacology.
Conclusion
Albrecht V Hodenberg's contributions to the field of antiarrhythmic agents highlight the critical role of innovation in medicine. His patent on metabolites of pirmenol represents a significant advancement in the treatment of heart conditions. Through his work, Hodenberg continues to impact the pharmaceutical industry positively.